Barr Sued Over Plan For Schizophrenia Drug

By Erik Larson · March 21, 2007, 12:00 AM EDT

Japanese drug maker Otsuka Pharmaceutical Co. Ltd. has filed a patent infringement lawsuit against Barr Pharmaceuticals Inc. over its plan to manufacture a generic version of Otsuka's schizophrenia drug, Abilify....

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Recent Articles By Erik

May 03, 2007
FDA Gives Mylan Tentative OK On Generic Femara
April 18, 2007
FDA Seizes Products From Device Maker
April 16, 2007
Ariad Sues Amgen, Wyeth Over Enbrel
April 05, 2007
Invalid Patent Correction Leads To Reversal
April 03, 2007
Bristol-Myers Subpoenaed Over Plavix Deal
April 02, 2007
Purdue, Impax Settle Oxycontin Litigation
March 29, 2007
Eckerd Prevails In Appeal Of FLSA Case
March 28, 2007
Tyco Files Suit Over Generic Sleep Aid
March 22, 2007
Pharmaceutical Holdings Admits Infringement In Deal
March 22, 2007
Amgen Asks High Court To Hear Landmark Case